SUSMED is proud to announce that it was approved for listing on TSE Mothers today.
We aims to realize “SUStainable MEDicine” by leveraging digital technology, such as developing DTx as a new effective treatment, providing clinical trial system for efficient drug discovery and machine learning system for utilization of medical data.
We would like to take this occasion to expand the business much further with an ambition to solve social issues in medical field.